Video: Does remdesivir work for COVID-19?

mediabest

The first double-blind, randomized, placebo-controlled study was published in the New England Journal of Medicine. The researchers discovered that patients treated with the drug were on average sick for less time – an average of 11 days versus 15.

They also found some evidence that the drug appeared to slightly reduce severity of the disease, and to slightly reduce the fatality rate. There was no indication that Remdesivir could be used to completely cure COIVD-19. More studies are needed to determine effective dosing strategies to reduce severity and duration of illness, and to better understand the impact of the drug on different kinds of patients.

https://youtube.com/watch?v=SCklcZUSW1A%3Fcolor%3Dwhite
Source: Read Full Article

Related posts:
  1. New COVID-19 info for gastroenterologists and patients
  2. ‘We’re right to be optimistic,’ says epidemiologist about search for COVID-19 vaccine
  3. Shorter radiotherapy treatment for bowel cancer patients during COVID-19
  4. Created for anthrax attacks, cold plasma air filter is being prepped to combat COVID-19
  5. 45.4 percent of U.S. adults at risk for complications with COVID-19